Skip to content

The Pilot Study on Development and Effectiveness of an Executive Function Improvement Program for Alcohol-Use Disorder-With an Understanding of Difficulties in Living-

The Pilot Study on Development and Effectiveness of an Executive Function Improvement Program for Alcohol-Use Disorder-With an Understanding of Difficulties in Living-

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1020250048
Enrollment
30
Registered
2026-02-13
Start date
2026-02-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism or Alcohol use disorder Alcoholism, alcohol use disorder, cognitive impairment, executive function

Interventions

This program is a group based cognitive training program called Ninto-re Cognitive Training. The intervention consists of a total of 12 sessions, including one initial session for goal setting and ori
MeSH Unique ID: D000091942
Cognitive Training

Sponsors

Kikuchi Sayaka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria will be included: Patients diagnosed with alcohol dependence or alcohol use disorder. Patients aged 20 to 65 years. Patients who are currently employed or who wish to be employed in the future. Patients living in the community.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded: Patients diagnosed with dementia, including alcohol-related dementia (patients scoring 20 points or below on the Montreal Cognitive Assessment [MoCA] will be excluded). Patients with a history of or a diagnosis of organic brain disorders, such as cerebral infarction or traumatic brain injury. Patients diagnosed with psychiatric disorders, including schizophrenia, mood disorders, or neurodevelopmental disorders. Patients deemed inappropriate for participation in the study by the principal investigator or co-investigators. Patients who are judged by the responsible personnel at the participating facility to be unable to continue participation in the study due to poor physical condition or unstable mental status

Design outcomes

Primary

MeasureTime frame
Executive function will be assessed using the Frontal Assessment Battery (FAB). The total score will be measured before and after the intervention to evaluate the effectiveness of the program.

Secondary

MeasureTime frame
Secondary outcomes include attention (Trail Making Test), impulsivity (Stroop Test), self-efficacy (General Self-Efficacy Scale), and executive function (Zoo Map Test and Modified Six Elements Test of the Behavioural Assessment of the Dysexecutive Syndrome), assessed before and after the intervention. Global cognitive function will be screened using the Montreal Cognitive Assessment Japanese version (MoCA-J). Qualitative data on perceived changes in difficulties in daily life will be collected through semi-structured focus group and individual interviews after the intervention.

Contacts

Public ContactSayaka Kikuchi

MP in Rehabilitation Science, Health Sciences, Graduate School of Medicine, Akita University

sakuring69@gmail.com+81-18-884-6543

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026